Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
Abstract |
|
Authors | Fei Yu, Rong Xiang, Xiaoqian Deng, Lili Wang, Zhengsen Yu, Shijun Tian, Ruiying Liang, Yanbai Li, Tianlei Ying, Shibo Jiang |
Journal | Signal transduction and targeted therapy
(Signal Transduct Target Ther)
Vol. 5
Issue 1
Pg. 212
(09 22 2020)
ISSN: 2059-3635 [Electronic] England |
PMID | 32963228
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Neutralizing
- Antibodies, Viral
- Epitopes
- Receptors, Virus
- Spike Glycoprotein, Coronavirus
- Peptidyl-Dipeptidase A
- ACE2 protein, human
- Angiotensin-Converting Enzyme 2
|
Topics |
- Angiotensin-Converting Enzyme 2
- Antibodies, Monoclonal
(biosynthesis, chemistry)
- Antibodies, Neutralizing
(biosynthesis, chemistry)
- Antibodies, Viral
(biosynthesis, chemistry)
- Betacoronavirus
(drug effects, immunology, pathogenicity)
- COVID-19
- Coronavirus Infections
(immunology, prevention & control, virology)
- Cross Reactions
- Epitopes
(chemistry, immunology, metabolism)
- Humans
- Models, Molecular
- Pandemics
(prevention & control)
- Peptidyl-Dipeptidase A
(chemistry, immunology, metabolism)
- Pneumonia, Viral
(immunology, prevention & control, virology)
- Protein Binding
- Protein Structure, Secondary
- Receptors, Virus
(chemistry, immunology, metabolism)
- Severe acute respiratory syndrome-related coronavirus
(drug effects, immunology, pathogenicity)
- SARS-CoV-2
- Severe Acute Respiratory Syndrome
(immunology, prevention & control, virology)
- Spike Glycoprotein, Coronavirus
(chemistry, immunology, metabolism)
- Virion
(immunology, ultrastructure)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|